Levoleucovorin

Overview

Levoleucovorin (Levofolinic acid; Levofolene) is the pharmacologically and orally active levoisomer of Folinic acid ( HY-17556 ), a synthetic folate analogue. Levoleucovorin can inhibit LOXL2 with an IC 50 of 68.81 μM. Levoleucovorin can inhibit cancer cells proliferation, migration and induce apoptosis . Levoleucovorin can be used as a rescue agent for high-dose Methotrexate ( HY-14519 ). Levoleucovorin can reduce the frequency of embryonic malformations. Levoleucovorin can be used for the research of can and endocrinology , such as breast cancer and osteosarcoma.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Breast Cancer | Products > Signaling Pathways > Cytoskeleton | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Lysyl Oxidase | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-127009
• CAS No.: 68538-85-2
• Molecular Formula: C20H23N7O7
• Molecular Weight: 473.44
• Purity: 98.53%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source